Cagrilintide
A long-acting amylin analog studied in combination with semaglutide (CagriSema) in satiety and metabolic research models.
Half-life
~7 days
Typical vial
5 mg / 10 mg
Mechanism
Amylin receptor agonism studied for satiety, gastric emptying, and glucagon suppression.
Research Applications
- Satiety models
- Combination GLP-1/amylin
- Metabolic studies
Handling & Storage
Store lyophilized at -20°C. Reconstitute and refrigerate.
Compliance notice: All materials are sold strictly for in vitro laboratory research. Not a drug, supplement, food, or cosmetic. Not for human or veterinary use, diagnosis, treatment, or consumption. No medical claims are made or implied. Buyers must be qualified researchers ≥21 years of age and agree to handle materials in compliance with all applicable local, state, and federal laws.